Cellarion — 5 iPSC Clinical Trials Planned to be Initiated in Q2 & Q3 2026

Cellarion is progressing its iPSC biobank platform with 5 clinical trials planned for Q2 and Q3 2026, targeting $67M in Year 5 revenue — one of the most capital-efficient iPSC programs in the industry.